Mersana Therapeutics Earnings Surprises image   This MRSN earnings surprises page last updated 3/13/2024
Mersana Therapeutics Earnings Surprises Chart
PeriodExpectedActualSurprise
Q3 2023 -0.36 -0.35 +0.01 (-3%)
Q2 2023 -0.50 -0.47 +0.03 (-6%)
Q1 2023 -0.44 -0.52 -0.08 (+18%)
Q4 2022 -0.50 -0.44 +0.06 (-12%)
Q3 2022 -0.09 -0.61 -0.52 (+578%)
Q2 2022 -0.52 -0.55 -0.03 (+6%)
Q3 2021 -0.58 -0.63 -0.05 (+9%)
Q2 2021 -0.50 -0.59 -0.09 (+18%)
Q4 2020 -0.32 -0.42 -0.10 (+31%)
Q2 2020 -0.30 -0.33 -0.03 (+10%)
Q1 2020 -0.37 -0.35 +0.02 (-5%)
Q4 2019 -0.38 -0.34 +0.04 (-11%)
Q3 2019 -0.37 -0.35 +0.02 (-5%)
Q2 2019 -0.38 -0.36 +0.02 (-5%)
Q1 2019 -0.02 0.70 +0.72 (-3600%)
Q4 2018 -0.69 -0.97 -0.28 (+41%)
Q3 2018 -0.59 -0.75 -0.16 (+27%)
Q2 2018 -0.58 -0.54 +0.04 (-7%)
Q1 2018 -0.61 -0.54 +0.07 (-11%)
Q4 2017 -0.52 -0.61 -0.09 (+17%)
Q3 2017 -0.45 -0.35 +0.10 (-22%)
Mersana Therapeutics Revenue Surprises Chart
PeriodExpectedActualSurprise
Q3 2023 9.35M 7.70M -1.65M (-18%)
Q2 2023 8.45M 10.65M +2.20M (+26%)
Q1 2023 18.29M 7.80M -10.49M (-57%)
Q4 2022 15.28M 14.69M -0.59M (-4%)
Q3 2022 13.57M 5.57M -8.00M (-59%)
Q2 2022 2.18M 4.28M +2.10M (+96%)
Q3 2021 100000 11000 -89000 (-89%)
Q2 2021 140000 11000 -0.13M (-92%)
Q4 2020 170000 10000 -0.16M (-94%)
Q2 2020 300000 796000 +496000 (+165%)
Q1 2020 390000 11000 -0.38M (-97%)
Q4 2019 290000 42000 -0.25M (-86%)
Q3 2019 290000 844000 +554000 (+191%)
Q2 2019 740000 202000 -0.54M (-73%)
Q1 2019 20.60M 41.03M +20.43M (+99%)
Q4 2018 3.92M 1.19M -2.73M (-70%)
Q3 2018 4.07M 2.15M -1.92M (-47%)
Q2 2018 3.87M 4.19M +321000 (+8%)
Q1 2018 3.99M 3.06M -0.93M (-23%)
Q4 2017 3.82M 3.26M -0.56M (-15%)
Q3 2017 3.65M 6.27M +2.62M (+72%)
Quotes delayed 20 minutes

Email EnvelopeFree MRSN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Dollar Tree (DLTR): 3/13/2024 6:30 AM
Liquidia (LQDA): 3/13/2024 6:30 AM
Target Hospitality (TH): 3/13/2024 6:45 AM
Sharecare (SHCR): 3/13/2024 7:00 AM
Petco Health and Wellness (WOOF): 3/13/2024 7:00 AM
WideOpenWest (WOW): 3/13/2024 7:00 AM
iSpecimen (ISPC): 3/13/2024 7:30 AM
Aadi Bioscience (AADI): 3/13/2024 8:00 AM
Optical Cable (OCC): 3/13/2024 8:00 AM
Vera Bradley (VRA): 3/13/2024 8:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

Riot Platforms (RIOT): 3/12/2024 5:00 PM
Anixa Biosciences (ANIX): 3/12/2024 5:00 PM
Eastern Co (EML): 3/12/2024 After close
PHX Minerals (PHX): 3/12/2024 After close
Oportun Financial (OPRT): 3/12/2024 After close
Allbirds (BIRD): 3/12/2024 After close
BRT Apartments (BRT): 3/12/2024 After close
Vintage Wine Estates (VWE): 3/12/2024 After close
Aterian (ATER): 3/12/2024 After close
Doma Holdings (DOMA): 3/12/2024 After close

More from the Earnings History archive
Mersana Therapeutics (MRSN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MRTX Historical Earnings
MRVI Historical Earnings
MSON Historical Earnings
MTCR Historical Earnings
MTEM Historical Earnings
MXCT Historical Earnings
MYGN Historical Earnings
MYMD Historical Earnings
NAOV Historical Earnings
NARI Historical Earnings
On this page we presented the MRSN earnings surprises information for Mersana Therapeutics, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on MRSN (or any other given stock) can benefit from researching all of the Mersana Therapeutics past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Mersana Therapeutics earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about MRSN's next earnings report. In your continued research on Mersana Therapeutics we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for MRSN. Thanks for visiting, and the next time you need to research MRSN earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: THRM Videos, SIFI Split History, TNXP Historical Stock Prices.

 

Mersana Therapeutics Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.